{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:04Z","timestamp":1707524224755},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,24]]},"DOI":"10.7759\/cureus.11689","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T04:18:54Z","timestamp":1606277934000},"source":"Crossref","is-referenced-by-count":0,"title":["Statin-Associated Necrotizing Myopathy: A Feared Complication"],"prefix":"10.7759","author":[{"given":"Suong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha Ann","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Apenteng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation. 2019, 140:10.1161\/cir.0000000000000678","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198205000-00002","article-title":"The spectrum of rhabdomyolysis","volume":"61","author":"Gabow PA","year":"1982","unstructured":"Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine. 1982, 61:141-152. 10.1097\/00005792-198205000-00002","journal-title":"Medicine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.13r06cp","article-title":"Mechanism of statin-induced rhabdomyolysis","volume":"123","author":"Sakamoto K","year":"2013","unstructured":"Sakamoto K, Kimura J. Mechanism of statin-induced rhabdomyolysis. J Pharmacol Sci. 2013, 123:289-294. 10.1254\/jphs.13r06cp","journal-title":"J Pharmacol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo A","year":"2010","unstructured":"Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B, Phys Biol Sci. 2010, 86:484-493. 10.2183\/pjab.86.484","journal-title":"Proc Jpn Acad Ser B, Phys Biol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham DJ","year":"2004","unstructured":"Graham DJ, Staffa J, Shatin D, et al.. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004, 292:2585-2590. 10.1001\/jama.292.21.2585","journal-title":"JAMA"},{"key":"ref6","unstructured":"Rosuvastatin NDA 21-366 N000 Resubmission Amendment. (2003). Accessed. May 21, 2020: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-366_Crestor_Medr_P1.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen KE","year":"2005","unstructured":"Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005, 165:2671-2676. 10.1001\/archinte.165.22.2671","journal-title":"Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1179547616688231","article-title":"A case of statin-associated autoimmune myopathy","volume":"10","author":"Sweidan AJ","year":"2017","unstructured":"Sweidan AJ, Leung A, Kaiser CJ, Strube SJ, Dokukin AN, Romansky S, Farjami S. A case of statin-associated autoimmune myopathy. Clin Med Case Rep. 2017, 10:10.1177\/1179547616688231","journal-title":"Clin Med Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/atv.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American Heart Association","volume":"39","author":"Newman CB","year":"2019","unstructured":"Newman CB, Preiss D, Tobert JA, et al.. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscl Throm Vas. 2019, 39:38-81. 10.1161\/atv.0000000000000073","journal-title":"Arterioscl Throm Vas"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000168053","article-title":"Reversible hepatic dysfunction associated with rhabdomyolysis","volume":"10","author":"Akmal M","year":"1990","unstructured":"Akmal M, Massry SG. Reversible hepatic dysfunction associated with rhabdomyolysis. Am J Nephrol. 1990, 10:49-52. 10.1159\/000168053","journal-title":"Am J Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24606","article-title":"Diagnostic evaluation of rhabdomyolysis","volume":"51","author":"Nance JR","year":"2015","unstructured":"Nance JR, Mammen AL. Diagnostic evaluation of rhabdomyolysis. Muscle Nerve. 2015, 51:793-810. 10.1002\/mus.24606","journal-title":"Muscle Nerve"},{"key":"ref12","article-title":"Immune-mediated necrotizing myopathy due to statins exposure","volume":"37","author":"Villa L","year":"2018","unstructured":"Villa L, Lerario A, Calloni S, et al.. Immune-mediated necrotizing myopathy due to statins exposure. Acta Myol. 2018, 37:257-262.","journal-title":"Acta Myol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies","volume":"48","author":"Mohassel P","year":"2013","unstructured":"Mohassel P, Mammen AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve. 2013, 48:477-483. 10.1002\/mus.23854","journal-title":"Muscle Nerve"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21486","article-title":"Immune\u2010mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable\u2010Esposito P","year":"2009","unstructured":"Grable\u2010Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune\u2010mediated necrotizing myopathy associated with statins. Muscle Nerve. 2009, 41:185-190. 10.1002\/mus.21486","journal-title":"Muscle Nerve"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40124-statin-associated-necrotizing-myopathy-a-feared-complication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:05Z","timestamp":1707506465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40124-statin-associated-necrotizing-myopathy-a-feared-complication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.11689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,24]]}}}